PPAR-gamma agonist rosiglitazone stops the progressive dopaminergic degeneration induced by chronic MPTP in mice

被引：0
|
作者：
Carta, A. [1 ]
Frau, L. [1 ]
机构：
[1] Univ Cagliari, Toxicol, Cagliari, Italy
来源：
PARKINSONISM & RELATED DISORDERS | 2009年 / 15卷
关键词：
D O I：
10.1016/S1353-8020(09)70473-0
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P2.122
引用
收藏
页码：S122 / S122
页数：1
相关论文
共 50 条
  • [21] Engeletin ameliorates sevoflurane-induced cognitive impairment by activating PPAR-gamma in neonatal mice
    Jiang, Su
    Xiong, Ying
    Wang, Xinyan
    NEUROPATHOLOGY, 2023, 43 (06) : 431 - 440
  • [22] Damage to vascular endothelial cells by high insulin levels is associated with increased expression of ChemR23, and attenuated by PPAR-gamma agonist, rosiglitazone
    Hao, Fei
    Mu, Jia-wei
    Zhang, Hui-juan
    Kuang, Hong-yu
    Yu, Qiu-xia
    Bai, Meng-meng
    Meng, Ping
    NEUROENDOCRINOLOGY LETTERS, 2015, 36 (01) : 59 - 66
  • [23] Nicotine, but not cotinine, partially protects dopaminergic neurons against MPTP-induced degeneration in mice
    Parain, K
    Marchand, V
    Dumery, B
    Hirsch, E
    BRAIN RESEARCH, 2001, 890 (02) : 347 - 350
  • [24] Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and α-synuclein inclusions
    Gibrat, Claire
    Saint-Pierre, Martine
    Bousquet, Melanie
    Levesque, Daniel
    Rouillard, Claude
    Cicchetti, Francesca
    JOURNAL OF NEUROCHEMISTRY, 2009, 109 (05) : 1469 - 1482
  • [25] FKBP51 Null Mice Are Resistant to Diet-Induced Obesity and the PPARγ Agonist Rosiglitazone
    Stechschulte, Lance A.
    Qiu, Bin
    Warrier, Manya
    Hinds, Terry D., Jr.
    Zhang, Man
    Gu, Hao
    Xu, Yuxue
    Khuder, Saja S.
    Russo, Lucia
    Najjar, Sonia M.
    Lecka-Czernik, Beata
    Yong, Weidong
    Sanchez, Edwin R.
    ENDOCRINOLOGY, 2016, 157 (10) : 3888 - 3900
  • [26] Rosiglitazone, a PPAR gamma agonist: Potent promoter of hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers
    Lubet, Ronald A.
    Fischer, Susan M.
    Steele, Vernon E.
    Juliana, M. Margaret
    Desmond, Renee'
    Grubbs, Clinton J.
    INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (10) : 2254 - 2259
  • [27] The PPAR Gamma Agonist Rosiglitazone Protects Against Wnt Signaling In Hyperoxia-Induced Neonatal Rat Lung Injury
    Dasgupta, Chiranjib
    Wang, Ying
    Sakurai, Reiko
    Torday, John S.
    Rehan, Virender
    FASEB JOURNAL, 2008, 22
  • [28] Platelet-activating factor receptor knockout mice are protected from MPTP-induced dopaminergic degeneration
    Kim, Beom Keun
    Shin, Eun-Joo
    Kim, Hyoung-Chun
    Chung, Yoon Hee
    Dang, Duy-Khanh
    Jung, Bae-Dong
    Park, Dae-Hun
    Wie, Myung Bok
    Kim, Won-Ki
    Shimizu, Takao
    Nabeshima, Toshitaka
    Jeong, Ji Hoon
    NEUROCHEMISTRY INTERNATIONAL, 2013, 63 (03) : 121 - 132
  • [29] PPAR-Gamma Agonist-Induced Telomerase Activation in Endothelial Cells and Endothelial Progenitor Cells is Mediated by the Survival Kinase Akt
    Werner, Christian
    Bakogiannis, Constantinos
    Boehm, Michael
    Laufs, Ulrich
    CIRCULATION, 2011, 124 (21)
  • [30] Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats
    Lee, Eun Young
    Lee, Jeong Eun
    Park, Jae Hyeon
    Shin, In Chul
    Koh, Hyun Chul
    TOXICOLOGY LETTERS, 2012, 213 (03) : 332 - 344
12345